Osteopore Limited announced its Chief Technology Officer (CTO), Dr. Lim Jing, has been appointed as the Company's Chief Operating Officer (COO), effective 1 May 2022. As Chief Operations Officer, Dr. Lim Jing will be responsible for overseeing the daily business and administrative operations, assessing and enhancing the efficiency of internal and external operational processes, and collaborating with management and other stakeholders to identify initiatives to increase the value of the company. With over a decade of experience in tissue engineering research, and a deep understanding of the Company's novel technology, Dr. Lim Jing will also continue his role as Osteopore's Chief Technology Officer - in conjunction with the newly appointed role of Chief Operating Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.065 AUD | -7.14% | +22.64% | -90.15% |
06-06 | Osteopore Advances Development of Dental Implant Project; Shares Surge 33% | MT |
05-23 | Osteopore Raises AU$23,312 Following Exercise of Options | MT |
1st Jan change | Capi. | |
---|---|---|
-90.15% | 5.3M | |
-5.27% | 181B | |
-0.05% | 108B | |
-1.50% | 69.41B | |
-7.12% | 45.85B | |
+15.24% | 46.61B | |
+7.97% | 42.61B | |
+18.56% | 30.71B | |
+16.92% | 25.63B | |
-6.84% | 23.32B |
- Stock Market
- Equities
- OSX Stock
- News Osteopore Limited
- Osteopore Limited Announces Appointment of Dr. Lim Jing as Chief Operating Officer